Sign Up Today and Learn More About Lyndra Therapeutics Stock
Invest in or calculate the value of your shares in Lyndra Therapeutics or other pre-IPO companies through EquityZen's platform.
Lyndra Therapeutics Stock (LYDT)
Lyndra Therepeutics creates therapies for long-term drug release in an oral dose form.
About Lyndra Therapeutics Stock
Founded
2015
Headquarters
Watertown, MA, US
Industries
Science and Engineering, Health Care, Biotechnology
Lyndra Therapeutics Press Mentions
Stay in the know about the latest news on Lyndra Therapeutics
Materials architecture for gastric residence systems
patents • Apr 02, 2025
Manufacturing methods for gastric residence systems
patents • Apr 02, 2025
Biotech layoff tracker: 21 companies cut 1,000 jobs in Q1 2025
bizjournals • Apr 01, 2025
US-based Lyndra Therapeutics ceases operations due to “insufficient funding”, says Sun Pharma
thehindubusinessline • Mar 27, 2025
Five things: Credit union rebrands, biotech shutdowns, M&A deals, and run, little otters, run
bizjournals • Mar 26, 2025
Lyndra Therapeutics Management
Leadership team at Lyndra Therapeutics
Executive Chairman & Co-Founder
Amy Schulman
Co-Founder
Colin R. Gardner
Join now and verify your accreditation status to gain access to:
- Lyndra Therapeutics Current Valuation
- Lyndra Therapeutics Stock Price
- Lyndra Therapeutics Management
- Available deals in Lyndra Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Lyndra Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Lyndra Therapeutics Revenue and Financials
- Lyndra Therapeutics Highlights
- Lyndra Therapeutics Business Model
- Lyndra Therapeutics Risk Factors
- Lyndra Therapeutics Research Report from SACRA Research
Trading Lyndra Therapeutics Stock
How to invest in Lyndra Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Lyndra Therapeutics through EquityZen funds. These investments are made available by existing Lyndra Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Lyndra Therapeutics stock?
Shareholders can sell their Lyndra Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
